DONATE

Pluripotency for organ regeneration

About

The generation of induced pluripotent stem cells (iPSCs), especially the generation of patient-derived pluripotent stem cells suitable for disease modelling in vitro, opens the door for the potential translation of stem-cell related studies into the clinic. 

Successful replacement, or augmentation, of the function of damaged cells by patient derived differentiated stem cells would provide a novel cell-based therapy for diseases. Since iPSCs resemble human embryonic stem cells (hESCs) in their ability to generate cells of three germ layers, patient-specific iPSCs offer definitive solutions for the ethical and histo-incompatibility issues related to hESCs. Indeed human iPSC (hiPSC)-based autologous transplantation is heralded as the future of regenerative medicine.

One of our aims is to generate and correct disease-specific hiPSCs for disease modelling and drug screening. The combination of gene-editing based methodologies together with the development of novel protocols for cell differentiation into relevant tissues/organs, provides a unique scenario for modelling disease progression, and the identification of molecular and cellular mechanisms leading to organ regeneration (Figure 1). In this regard we are particularly interested in generation of transgene-free and disease free patient derived hiPSCs for disease modelling and the discovery of novel therapeutic targets.  

We believe that the recovery of tissue function should not be restricted to the development of cell replacement therapies. In this regard, in our laboratory we take advantage of organisms that possess the ability to regenerate such as zebrafish, in order to understand which molecular and cellular pathways lead to organ regeneration.

Surprisingly, studies in neonatal mice have demonstrated that soon after birth this organism posses the capability to regenerate its heart. Taking advantage of such preliminary observations we are translating such analysis in order to understand if the mammalian neonatal kidney still posses the capability to regenerate, and more importantly, if we are able to dissect the epigenetic and cellular mechanisms leading to those responses. 

Lastly, and in an effort to fully develop in vitro and ex vivo platforms for organ regeneration, in our lab we are focused in the development of reporter cell lines for different transcription factors essential for tissue-specific commitment and differentiation (i.e: renal and cardiac lineages). The possibility to combine pluripotent stem cell lines together with decellularized matrices, functionalized biomaterials and ex vivo organoids offers and unprecedented opportunity for the immediate generation of patient-specific in vitro and ex vivo platforms for disease modelling and organ regeneration (Figure 2). 

Staff

Projects

NATIONAL PROJECTSFINANCERPI
Bioengeniería para mejorar la salud mediante de organoides y bioimpresión 3D (2021-2023)MINECO – Plataformas ISCIII de apoyo a la I+D+I en Biomedicina y Ciencias de la SaludNúria Montserrat
CARDIOPRINT Biofabricación avanzada multifunción en 3D para la generación de tejido cardiaco terapéutico a escala humana diseñado por ordenador (2021-2024)MICIU, Proyectos de I+D+i en líneas estratégicasNúria Montserrat
CAKUTORG Desarrollando nuevas estrategias para entender y tratar las anomalías congénitas del riñón y del tracto urinario mediante organoides (2021-2024)MICIU, Retos investigación: Proyectos I+D Núria Montserrat
Identifying SARS-CoV-2- host cell interactions exploiting CRISPR/Cas9 engineered human organoids: through the development of specific therapies against COVID19 (2020-2022)FBBVA Núria Montserrat
CHONDREG · Identification of the epigenetic mechanisms preventing chondrocyte de-differentiation: generation of novel therapeutic strategies for the treatment of cartilage chronic osteochondral lesionsCIBERNuria Montserrat
Infarto de miocardio en jóvenes. Factores epigeneticos y nuevos marcadores de riesgo cardiovascular. Efecto de la modulación de la expresión de microRNAs y long-non coding RNAsISCIII(Collaborator)
INTERNATIONAL FUNDED PROJECTSFINANCERPI
ENGIORG Engineering kidney organoids to study the interplay between Tissue Mechanics and Metabolism: from development to disease (2021-2026)European Commission Núria Montserrat
ECaBox ECaBox “Eyes in a Care Box”: Regenerating human retina from resuscitated cadaveric eyes (2021-2025)European Commission, FET OPENNúria Montserrat
Engineering functional human kidneys and urinary tracts (2021-2024)Wellcome Leap Solicitation for Humans Organs, Physiology and Engineering (HOPE) Núria Montserrat
BRAV3. Computational biomechanics and bioengineering 3D printing to develop a personalized regenerative biological ventricular assist device to provide lasting functional support to damaged hearts (2020-2024)European CommissionNúria Montserrat
MAD-CoV 2 · Modern approaches for developing antivirals against SARS-CoV 2 (2020-2024)European CommissionNúria Montserrat
R2U-Tox-Assay · Ready-to-use Toxicity Screening Assay based on iPS-Technologies (2020-2022)EIT HealthNúria Montserrat
PRIVATELY FUNDED PROJECTSFINANCERPI
SYSTORG Exploiting organoid model systems to explore systemic conditions worsening COVID19: merging cellular and genetic engineering (2021-2024)Fundació La Marató de TV3, TV3-Projectes de recerca La Marató TV3 Núria Montserrat
Identificació de noves dianes terapèutiques i biomarcadors de progressió del càncer de ronyó a través de models organoides i xenoempelts genèticament dissenyats per CRISPR (2020-2023)Fundació La Marató de TV3, TV3-Projectes de recerca La Marató TV3 Núria Montserrat
REPIRE · Regenerating photoreceptors in human retinal organoids to establish a treatment for Retinitis Pigmentosa (2018-2021)Fundación Bancaria “La Caixa”Núria Montserrat
FUNDRAISING PROJECTSFINANCERPI
Programa Faster Future 2020: COVID-19 (2021)FundraisingNúria Montserrat
FINISHED PROJECTSFINANCERPI
Identification of Kidney Cancer progression targets and biomarkers through CRISPR-engineered organoids and xenograft mouse models (2019-2020)Fundació La Marató de TV3Núria Montserrat
Generation of Isogenic Models of Clear Cell Renal Cell Carcinoma (ccRCC) using CRISPR-engineered Kidney Organoids, for the identification of diagnostic biomarkers (2017-2021)Fundación AECCNúria Montserrat
EPIORG · Cómo modelar la Nefropatía Diabética: restableciendo el epigenoma en organoides renales diabéticos inducidos (2018-2020)MINECO, Retos investigación: Proyectos I+DNúria Montserrat
MECHANORG · Como integrar señales mecánicas y metabólicas en organoides renales para el modelado de patologías humanas (2019-2020)MINECO, Acciones Dinamización Europa InvestigaciónNúria Montserrat
Modelling Diabetic Nephropathy targeting DNA methylation: engineering the epigenome in kidney (2019-2020)EFSD European Foundation for the Study of DiabetesNúria Montserrat
REGMAMKID · How to regenerate the mammalian kidney (2015-2021)European Commission, ERC-StGNúria Montserrat
REPROMICRO · Reprogramacion y regeneracion tisular a partir de microvesiculas derivadas de celulas madre de pluripotencia inducida (2017-2019)Ministerio de Economía y Competitividad, Explora Ciencia Nuria Montserrat
Desarrollo de nuevas estrategias para el tratamiento de la enfermedad renal (2015-2017)MINECONuria Montserrat
TRATENFREN · Desarrollo de nuevas estrategias para el tratamiento de la enfermedad renal (2015-2017)MINECO, Retos investigación: Proyectos I+DNuria Montserrat
Regenerative medicine for Fanconi anemia: generation of disease-free patient-specific iPS (2013-2016)Fundació La Marató de TV3Nuria Montserrat
ACE2-ORG · Development of a human cellular plaform unveilling Angiotensin-converting enzyme 2 (ACE2) – sars-CoV-2 interactions (2020-2021)ISCIIINúria Montserrat
Red TERCEL · Red de Terapia Celular (2017-2021)MINECO, ISCIII(Collaborator)
EPIORGABOLISM Diabetic nephropathy modelling in hESC-derived 3D (2019-2021)European Commission, MARIE CURIE – IFCarmen Hurtado

Publications



Equipment

  • Real Time QuantStudio 5
  • SimpliAmp thermocycler
  • Eppendorf 5415D centrifuge
  • Allegra X-15 R centrifuge
  • Gyrozen 1248 centrifuge
  • BioUltra 6 Telstar culture Hood 2x
  • AH-100 Telstar primary culture Hood
  • Binder CB 60 incubators 2x
  • Controltecnica ASTEC SCA 165 incubator
  • Controltecnica ZC 180 incubator
  • Bioruptor Pico sonicator
  • Thermomixer C thermal block
  • Leica DMS1000 and DMIL Led microscopes
  • Leica DMi1 microscope
  • Leica MZ 10F magnifying glass
  • Safe Imager 2.0 transilluminator

Collaborations

  • Juan Carlos Izpisua Belmonte
    Salk Institute for Biological Studies
  • Dr. Josep Maria Campistol Plana
    Experimental Laboratory of Nephrology and Transplantation, Hospital Clínic, Barcelona
  • Peter Hohestein
    The Roslin Institute, University of Edinburgh
  • Dr. Pere Gascón Vilaplana
    Head of Oncology Service/Molecular and Translational Oncology Laboratory, IDIBAPS
  • Gloria Calderon
    Embryotools SL
  • Pura Muñoz Cánovas
    Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra
  • Dr. Pedro Guillén
    Director Clínica Cemtro, Madrid
  • Dr. Francisco Fernández Avilés
    Head of Cardiology Service, Hospital General Universitario Gregorio Marañón, Madrid
  • Dr María Eugenia Fernández
    Unit of Cell Production, Hospital Gregorio Marañón, Madrid
  • Joaquin Gutiérrez Fruitós
    University of Barcelona
  • Dr. Pere Roca-Cusachs
    IBEC
  • Dr. Elena Martínez
    IBEC
  • Dr. Cristina Eguizabal  Argaiz
    Centro Vasco de Transfusion y Tejidos Humanos (CVTTH), Bizkaia
  • Dr. Antonio Alcaraz
    Head of Urology, Hospital Clínic, Barcelona
  • Dr. Oriol Casanovas
    Head of Tumour Angiogenesis Group, IDIBELL

News

Researchers at IBEC and ICMAB develop a flexible, cheap and biocompatible transistor platform able to record an electrocardiogram of cells and micro-tissues during long periods of time. The platform, based on organic transistor technology (EGOFET), can also measure the effect of drugs on beating cells, as cardiomyocytes, opening the door to several applications such as implantable devices for health.

A research team develop biotransistors able to hear small beats of live

Researchers at IBEC and ICMAB develop a flexible, cheap and biocompatible transistor platform able to record an electrocardiogram of cells and micro-tissues during long periods of time. The platform, based on organic transistor technology (EGOFET), can also measure the effect of drugs on beating cells, as cardiomyocytes, opening the door to several applications such as implantable devices for health.

Three IBEC projects have been selected to receive funding from “La Marató 2018: Against Cancer.” One of the projects is led by the researcher Pere Roca-Cusachs and the other two are co-led by the researchers Xavier Trepat and Núria Montserrat. The awarding ceremony took place on October 30 in the Auditorium of the Academy of Medical and Health Sciences of Catalonia and the Balearic Islands. In this edition, over the 188 evaluated projects, 43 have been selected by an international committee of experts in cancer based on their excellence, methodology and relevance. La Marató de TV3, together with Catalunya Ràdio, broadcasts its annual telethon to raise funds for scientific research into various diseases with a different theme each year.

IBEC recieves funding for three projects thanks to la Marató 2018

Three IBEC projects have been selected to receive funding from “La Marató 2018: Against Cancer.” One of the projects is led by the researcher Pere Roca-Cusachs and the other two are co-led by the researchers Xavier Trepat and Núria Montserrat. The awarding ceremony took place on October 30 in the Auditorium of the Academy of Medical and Health Sciences of Catalonia and the Balearic Islands. In this edition, over the 188 evaluated projects, 43 have been selected by an international committee of experts in cancer based on their excellence, methodology and relevance. La Marató de TV3, together with Catalunya Ràdio, broadcasts its annual telethon to raise funds for scientific research into various diseases with a different theme each year.

Last 9-11th of October took place in Beijing the workshop on “Engineering and Manufacture of Living Systems”. The aim of the workshop was to bring together multi-disciplinary researchers to review the latest advances and discuss the future directions in the design and manufacture of engineered living systems, and their integration amongst the researchers gathered at this international workshop. The major topics discussed during the workshop were: to consider issues related to translation of engineered living systems from the laboratory to the clinic and to industry, review enabling and emerging techniques for using pluripotent cells from various sources such as cell spheroids, organoids and organs-on-a-chip, discuss the ethical, societal and regulatory issues associated with the development and manufacture of engineered living systems and envision future research, development and synergies at the integration and interface of biomanufacturing and engineering living systems amongst others. The meeting was organised by Tsinghua University and the Massachusetts Institute of Technology.

Josep Samitier and Núria Montserrat at the “Engineering and Manufacture of Living Systems” workshop in China

Last 9-11th of October took place in Beijing the workshop on “Engineering and Manufacture of Living Systems”. The aim of the workshop was to bring together multi-disciplinary researchers to review the latest advances and discuss the future directions in the design and manufacture of engineered living systems, and their integration amongst the researchers gathered at this international workshop. The major topics discussed during the workshop were: to consider issues related to translation of engineered living systems from the laboratory to the clinic and to industry, review enabling and emerging techniques for using pluripotent cells from various sources such as cell spheroids, organoids and organs-on-a-chip, discuss the ethical, societal and regulatory issues associated with the development and manufacture of engineered living systems and envision future research, development and synergies at the integration and interface of biomanufacturing and engineering living systems amongst others. The meeting was organised by Tsinghua University and the Massachusetts Institute of Technology.

The researcher Núria Montserrat accompanies the president of the European Research Council (ERC) together with a selection of the best European researchers, at the Summer Davos annual Meeting, organised by the World Economic Forum (WEF). She has participated in several forums about how to work on more prosperous future and she explained how the research in organ regeneration that she is currently undertaking at IBEC can help in the fight against cancer. The Annual Meeting of the New Champions (AMNC) also known as Summer Davos, is one of the events that brings together the brightest minds on the planet to discuss issues related to scientific research, leadership, and innovation. On this occasion, the forum was from 1 to 3 July and was held in the Chinese city of Dailan with the participation of the European delegation composed of its president, the mathematician Jean-Pierre Bourguignon and ten of the most outstanding European scientists.

Núria Montserrat represents the european research council at the world economic forum in China

The researcher Núria Montserrat accompanies the president of the European Research Council (ERC) together with a selection of the best European researchers, at the Summer Davos annual Meeting, organised by the World Economic Forum (WEF). She has participated in several forums about how to work on more prosperous future and she explained how the research in organ regeneration that she is currently undertaking at IBEC can help in the fight against cancer. The Annual Meeting of the New Champions (AMNC) also known as Summer Davos, is one of the events that brings together the brightest minds on the planet to discuss issues related to scientific research, leadership, and innovation. On this occasion, the forum was from 1 to 3 July and was held in the Chinese city of Dailan with the participation of the European delegation composed of its president, the mathematician Jean-Pierre Bourguignon and ten of the most outstanding European scientists.

The President of the European Research Council, Jean-Pierre Bourguignon, visited last May 15th the Institute for Bioengineering of Catalonia (IBEC). The event was inaugurated by IBEC’s Director, Josep Samitier, who presented an overview on the cutting-edge research carried out at the institute in the fields of bioengineering and nanomedicine. Afterwards, ERC Grantees working at IBEC had the opportunity to explain the impact of ERC grants on their professional careers and established a dialogue with ERC President on the past, present and future of the European Research Council.

ERC President visits IBEC

The President of the European Research Council, Jean-Pierre Bourguignon, visited last May 15th the Institute for Bioengineering of Catalonia (IBEC). The event was inaugurated by IBEC’s Director, Josep Samitier, who presented an overview on the cutting-edge research carried out at the institute in the fields of bioengineering and nanomedicine. Afterwards, ERC Grantees working at IBEC had the opportunity to explain the impact of ERC grants on their professional careers and established a dialogue with ERC President on the past, present and future of the European Research Council.

Last Friday, Núria Montserrat was invited at the TV show “Terrícoles” at Betevé where she discussed with the journalist Milagros Pérez about organs and artificial tissues, stem cells, 3D bioprinters and bioinformatics, among other things.

Núria Montserrat: “We still don’t fully understand how cells develop”

Last Friday, Núria Montserrat was invited at the TV show “Terrícoles” at Betevé where she discussed with the journalist Milagros Pérez about organs and artificial tissues, stem cells, 3D bioprinters and bioinformatics, among other things.

Researchers from the IBEC have created, for the first time, 3D organoid cultures from pluripotent stem cells, which resemble human embryonic kidney tissue during the second trimester of pregnancy. Using biomaterials that mimic the embryonic microenvironment, researchers have also achieved mini-kidneys with relevant features for immediate use in renal disease modeling. A study published today in Nature Materials reports how researchers from IBEC have created organoids, or mini-organs, that resemble the human embryonic kidney, and how these 3D cultures mimic essential aspects during the formation of the kidney, such as distribution, functionality and specific organization of cells.

IBEC researchers generate mini-kidneys vascularized from stem cells

Researchers from the IBEC have created, for the first time, 3D organoid cultures from pluripotent stem cells, which resemble human embryonic kidney tissue during the second trimester of pregnancy. Using biomaterials that mimic the embryonic microenvironment, researchers have also achieved mini-kidneys with relevant features for immediate use in renal disease modeling. A study published today in Nature Materials reports how researchers from IBEC have created organoids, or mini-organs, that resemble the human embryonic kidney, and how these 3D cultures mimic essential aspects during the formation of the kidney, such as distribution, functionality and specific organization of cells.

IBEC is a driving force behind a major science festival that will be taking place across the city this year. The event was presented yesterday at a press conference held at the Amfiteatre Anatòmic de la Reial Acadèmia de Medicina and it is organized by the Ajuntament de Barcelona along with other top research centers. An initiative promoted by the Institut de Cultura de Barcelona (ICUB), Ciutat-Ciència is being planned by a committee of seven reseachers, including IBEC’s group leader Nuria Monstserrat. With a week of concentrated activity from 7th-11th February, Ciutat-Ciència will present today’s rapidly accelerating scientific advances to citizens and encourage debate and opinion.

IBEC participates in the First Biennial Ciutat-Ciència 2019

IBEC is a driving force behind a major science festival that will be taking place across the city this year. The event was presented yesterday at a press conference held at the Amfiteatre Anatòmic de la Reial Acadèmia de Medicina and it is organized by the Ajuntament de Barcelona along with other top research centers. An initiative promoted by the Institut de Cultura de Barcelona (ICUB), Ciutat-Ciència is being planned by a committee of seven reseachers, including IBEC’s group leader Nuria Monstserrat. With a week of concentrated activity from 7th-11th February, Ciutat-Ciència will present today’s rapidly accelerating scientific advances to citizens and encourage debate and opinion.

1 7 8 9 10

Jobs